CLAY THORNBURG: Open Payments
NPI 1710596424 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 46 payments from 17 companies in 2025. Trend: 2023 $339 · 2024 $385 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $250 |
| Novo Nordisk Inc | 8 | $163 |
| Amgen Inc. | 11 | $153 |
| Verona Pharma, Inc. | 2 | $144 |
| SK Life Science, Inc. | 1 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Dexcom, Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: Ohtuvayre, AIRSUPRA, BREZTRI, Ozempic, EVENITY, OTEZLA, Dexcom G6 Transmitter, Wegovy.
Industry payments across MO — which companies pay providers there.
